Increasing platelets without transfusion: is it time to introduce novel thrombopoietic agents in neonatal care? - Wikidata - awgldk - TriplyDB

Increasing platelets without transfusion: is it time to introduce novel thrombopoietic agents in neonatal care?

Increasing platelets without transfusion: is it time to introduce novel thrombopoietic agents in neonatal care?

http://www.wikidata.org/entity/Q33389236

about

Platelet transfusion in the neonatal intensive care unit: benefits, risks, alternatives.Do we know when to treat neonatal thrombocytopaenia?Distinct differences in platelet production and function between neonates and adults: implications for platelet transfusion practice.Thrombocytopenia in late preterm and term neonates after perinatal asphyxia.Mathematical model of platelet turnover in thrombocytopenic and nonthrombocytopenic preterm neonates Understanding thrombocytopenia: physiological role of microRNA in survival of neonatal megakaryocytes.Thrombocytopenia in Small-for-Gestational-Age Infants.

P2860

Q33397559-CE5408CB-7109-4F63-98C2-C86A4677734E Q33406651-35B7AC5E-CB14-4303-B592-B7BC2FDCA75F Q33409352-AE9081B7-6F13-471E-800F-CB594D4EFD04 Q33416836-A781573F-E74B-46C1-95CC-173D26E87D94 Q33418500-D126D9EF-DCEC-4310-9F71-6E4303DDA9C4 Q33423497-A3D3FACA-065A-4C86-9FCB-1ECA3F8F3E81 Q33424766-95A301E8-9750-46D2-B131-E6587C9B16DB

P2860

Increasing platelets without transfusion: is it time to introduce novel thrombopoietic agents in neonatal care?

http://www.wikidata.org/entity/Q33389236

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Increasing platelets without t ...... ietic agents in neonatal care?

@ast

Increasing platelets without t ...... ietic agents in neonatal care?

@en

type

label

Increasing platelets without t ...... ietic agents in neonatal care?

@ast

Increasing platelets without t ...... ietic agents in neonatal care?

@en

prefLabel

Increasing platelets without t ...... ietic agents in neonatal care?

@ast

Increasing platelets without t ...... ietic agents in neonatal care?

@en

P1433

Q33389236-AFBBA90F-63DA-4E82-A445-F93CEE30816B

P1476

Q33389236-1FE3A5F9-D20F-4473-AA47-636D837D30BB

P2093

Q33389236-53EAB827-3AEC-4287-96BB-06EBBB7D702F

Q33389236-90BE9E70-A9E9-422D-BABF-21B59F5C78FD

Q33389236-B9A57FDE-B3FB-4A3A-B3D7-D9070E089A7C

P2860

Q33389236-0281854A-EE10-41AF-8F52-4415D4EDA3C2

Q33389236-166C95FB-B539-42ED-A217-F10AD0ED43EA

Q33389236-2C1BF82A-0AA4-414C-B396-0D4D61331163

Q33389236-3367A01F-C011-4462-972E-59E2386F1AD0

Q33389236-36A01AA3-2100-40A5-B539-1297BF0A3731

Q33389236-3E920700-207E-4D4E-B36A-33DF9381F2F3

Q33389236-457B4D05-FCD1-4649-9D64-EB1428091B7F

Q33389236-4B62DECA-FFDD-4EEA-91EC-5AE2DD834E67

Q33389236-5A4A0770-B777-4B33-9550-72BDB0605C6E

Q33389236-5C12029C-5713-4D55-AB54-D0F73442035A

P2888

Q33389236-6E442DCB-552C-435D-936C-EBF60514E8F9

P304

Q33389236-C5EBD1EF-0A3F-492E-AD1A-06F7CF2F8CF8

P31

Q33389236-737A9465-8262-455F-9E0D-5FD633679D79

P356

Q33389236-D06FFA57-5257-4DA9-B093-E6034FDBDC5B

P433

Q33389236-4EEED37A-9C08-436E-A112-1C5FCE121588

P478

Q33389236-A212607C-480D-425E-B4F9-6FD3C350E2D6

P50

Q33389236-8541240B-23A8-43E2-9BC4-C46D448F6E0A

Q33389236-CDAC573B-FE7A-4745-B6CB-E70E81513527

P577

Q33389236-671C8713-4860-4F64-A4CC-9F00EBBC3300

P5875

Q33389236-3DD8CA7E-52AD-43CE-A811-4AA5A4626AF0

P6179

Q33389236-27D3D398-4600-416D-B68E-2E8DA9449D5D

P698

Q33389236-65B6BA9A-3F31-412F-8C4F-FCE7B3449195

P356

P1433

Journal of Perinatology

P1476

Increasing platelets without t ...... ietic agents in neonatal care?

@en

P2093

H Sallmon

http://www.w3.org/2001/XMLSchema#string

M C Sola-Visner

http://www.w3.org/2001/XMLSchema#string

Z-J Liu

http://www.w3.org/2001/XMLSchema#string

P2860

The molecular mechanisms that control thrombopoiesis

Congenital neutropenia

Current controversies in the management of the anemia of prematurity

A hematopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain

Thrombocytopenia among extremely low birth weight neonates: data from a multihospital healthcare system.

Plasma thrombopoietin concentrations in thrombocytopenic and non-thrombocytopenic patients in a neonatal intensive care unit.

Pharmacokinetics, pharmacodynamics, and safety of administering pegylated recombinant megakaryocyte growth and development factor to newborn rhesus monkeys.

Dose-response relationship of megakaryocyte progenitors from the bone marrow of thrombocytopenic and non-thrombocytopenic neonates to recombinant thrombopoietin.

Toward a rational use of recombinant thrombopoietin in the neonatal intensive care unit.

Thrombocytopenia caused by the development of antibodies to thrombopoietin.

P2888

P304

765-769

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JP.2010.50

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Ravi Kumar Gutti

Francisca Ferrer-Marín

P577

2010-04-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43248038

http://www.w3.org/2001/XMLSchema#string

P6179

1044657069

http://www.w3.org/2001/XMLSchema#string

P698

20410910

http://www.w3.org/2001/XMLSchema#string